| WKN: | 565131 |
| ISIN: | DK0010272202 |
| Land: | Dänemark |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Genmab-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 04. Januar 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2012 | 3,59 | 10,34 | 188,02% |
| 2 | 2006 | 18,15 | 51,02 | 181,10% |
| 3 | 2013 | 10,34 | 28,33 | 173,98% |
| 4 | 2015 | 48,87 | 126,06 | 157,95% |
| 5 | 2003 | 3,11 | 6,50 | 109,00% |
| 6 | 2004 | 6,50 | 13,51 | 107,85% |
| 7 | 2014 | 28,33 | 48,87 | 72,50% |
| 8 | 2020 | 198,40 | 325,00 | 63,81% |
| 9 | 2019 | 141,55 | 198,40 | 40,16% |
| 10 | 2025 | 200,40 | 272,30 | 35,88% |
| 11 | 2005 | 13,51 | 18,15 | 34,34% |
| 12 | 2016 | 126,06 | 156,99 | 24,54% |
| 13 | 2022 | 350,10 | 396,70 | 13,31% |
| 14 | 2021 | 325,00 | 350,10 | 7,72% |
| 15 | 2018 | 138,80 | 141,55 | 1,98% |
| 16 | 2026 | 272,30 | 268,30 | -1,47% |
| 17 | 2001 | 24,00 | 22,80 | -5,00% |
| 18 | 2017 | 156,99 | 138,80 | -11,59% |
| 19 | 2010 | 10,92 | 8,80 | -19,41% |
| 20 | 2007 | 51,02 | 41,06 | -19,52% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 22,80 | 3,11 | -86,36% |
| 2 | 2009 | 28,31 | 10,92 | -61,43% |
| 3 | 2011 | 8,80 | 3,59 | -59,20% |
| 4 | 2008 | 41,06 | 28,31 | -31,05% |
| 5 | 2024 | 286,10 | 200,40 | -29,95% |
| 6 | 2023 | 396,70 | 286,10 | -27,88% |
| 7 | 2007 | 51,02 | 41,06 | -19,52% |
| 8 | 2010 | 10,92 | 8,80 | -19,41% |
| 9 | 2017 | 156,99 | 138,80 | -11,59% |
| 10 | 2001 | 24,00 | 22,80 | -5,00% |
| 11 | 2026 | 272,30 | 268,30 | -1,47% |
| 12 | 2018 | 138,80 | 141,55 | 1,98% |
| 13 | 2021 | 325,00 | 350,10 | 7,72% |
| 14 | 2022 | 350,10 | 396,70 | 13,31% |
| 15 | 2016 | 126,06 | 156,99 | 24,54% |
| 16 | 2005 | 13,51 | 18,15 | 34,34% |
| 17 | 2025 | 200,40 | 272,30 | 35,88% |
| 18 | 2019 | 141,55 | 198,40 | 40,16% |
| 19 | 2020 | 198,40 | 325,00 | 63,81% |
| 20 | 2014 | 28,33 | 48,87 | 72,50% |